OSLO, Norway, April 29, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces four abstract presentations at the AUA 2025, highlighting the benefits of Blue Light ...
A diagnosis of stage 1 urothelial carcinoma can be overwhelming, but it is an early-stage cancer with excellent prognosis and ...
Genitourinary cancers require individualized treatment plans based on type, stage, and patient health, utilizing imaging, ...
When using a diagnostic tool, it is common see to more false-positives as the number of true-positives increases ( Table 1). The accuracy of fluorescence cystoscopy is also affected by previous ...
In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...
Bladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating continuous monitoring. Late detection often requires major surgeries, such as ...
Kidney cancer often starts without warning. One key sign is blood in the urine, but people may ignore it. Sometimes, it's just high blood pressure that doesn't respond to medicine. Many people find ...
Bladder cancer affects approximately 83,000 Americans each year, yet remains one of the most overlooked forms of cancer despite having excellent survival rates when caught early. This disconnect ...
A groundbreaking Indian study, the BART trial, highlights that radiation therapy post-surgery safely reduces pelvic relapse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback